Fabio Arpinelli

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. pmc The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
    Fabio Arpinelli
    Health Technology Assessment, Medical Department, GSK S p A Verona, Italy
    Health Qual Life Outcomes 4:85. 2006

Detail Information

Publications1

  1. pmc The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
    Fabio Arpinelli
    Health Technology Assessment, Medical Department, GSK S p A Verona, Italy
    Health Qual Life Outcomes 4:85. 2006
    ..Moreover, prescribing doctors and payers could benefit from subjective information to better define the value of drugs...